complications of tirzepatide Side Effects Insomnia: What the Evidence Shows Understanding Tirzepatide Side Effects, Risks

On June 18, 2025, Eccogene announced that the first patient had been dosed in the Phase 1b clinical trial of AZD5004/ECC5004 in China

coordinate medication changes with both your prescriber and mental health clinician

With heightened consumer interest in lower-cost options, Health Canada said growing interest in GLP-1 products for weight loss has prompted some people to turn to unauthorized or counterfeit products [Source: newswire.ca/news-releases/public-advisory-thinking-about-buying-glp-1-drugs-like-ozempic-or-mounjaro-beware-of-fake-or-unauthorized-products-844970747.html]

but current evidence remains preliminary.